XML 45 R4.htm IDEA: XBRL DOCUMENT v3.24.2Close
Consolidated Statements of Operations - USD ($)
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue:    
Manufacturing fees $ 54,120,731 $ 29,187,573
Licensing fees 2,504,397 4,967,541
Total revenue 56,625,128 34,155,114
Cost of manufacturing 30,268,025 17,561,093
Gross profit 26,357,103 16,594,021 Close
Operating expenses:    
Research and development 6,883,351 6,200,163
General and administrative 7,145,114 5,122,272
Impairment of intangible assets 292,807
Non-cash compensation through issuance of stock options 159,921 39,325
Depreciation and amortization 1,379,948 1,263,452
Total operating expenses 15,568,334 12,918,019 Close
Income from operations 10,788,769 3,676,002 Close
Other (expense) income:    
Change in fair value of derivative financial instruments - warrants (5,776,297) 415,126
Change in fair value of stock-based liabilities (5,743,468)
Interest expense and amortization of debt issuance costs (588,622) (1,112,707)
Gain from settlement agreements 1,761,792
Gain on sale of ANDA 1,000,000
Interest income 20,918 7,453
Other (expense) income, net (10,325,677) 309,872 Close
Income before income taxes 463,092 3,985,874 Close
Income tax benefit (expense) 19,645,539 (424,028) Close
Net income $ 20,108,631 $ 3,561,846 Close
Basic net income per share attributable to common shareholders $ 0.02 $ 0.00
Diluted net income per share attributable to common shareholders $ 0.02 $ 0.00
Basic weighted average Common Stock outstanding 1,015,443,363 1,012,911,346
Diluted weighted average Common Stock outstanding 1,023,225,623 1,012,911,346